Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AVGO vs MRNA✓SelectedUSD · MRNAAVGO vs MRNA performance historyLatest closeAs of-12.19%11/20
Stock and ETF performance explorer

AVGO vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,533.4%
MRNA return
+786.4%
Excess return
+747.1%
Maximum drawdown
-48.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-12.2%-2.2%-10.0%-12.1%
7D-12.3%-12.7%+0.4%-11.9%
30D-9.9%-20.7%+10.8%-9.2%
3M-16.2%+46.3%-62.5%-17.5%
6M-26.9%+305.2%-332.1%-33.7%
YTD-11.6%+561.2%-572.8%-23.3%
1Y-11.6%+772.1%-783.7%-25.0%
3Y+215.8%+147.0%+68.8%+185.4%
5Y+484.7%-26.1%+510.8%+445.8%
All+1,533.4%+786.4%+747.1%+1,498.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling